SCHLACHET DAVID

Director at PHARMOS CORP · on record since Jan 27, 2006
Director at BIOCANCELL THERAPEUTICS INC. · on record since Apr 29, 2010
Director at Lineage Cell Therapeutics, Inc. · on record since Apr 21, 2014

Insider trading activity of SCHLACHET DAVID

Transactions on record: 9; since Feb 24, 2004

Open-market buys: 1; $100K

Open-market sells: 0

Companies traded: 2; last filing Jul 5, 2017

Figures computed from official regulatory filings — .

Companies where SCHLACHET DAVID has traded

Lineage Cell Therapeutics, Inc.6 tx · $100K · Jul 5, 2017
PHARMOS CORP3 tx · Jan 27, 2006

Track record of SCHLACHET DAVID

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SCHLACHET DAVID

Co-insiders of SCHLACHET DAVID

AKKARAJU SRINIVASPHARMOS CORP
Amin DiptiLineage Cell Therapeutics, Inc.
ANDREWS DEBORAH JLineage Cell Therapeutics, Inc.
Angel MatthewLineage Cell Therapeutics, Inc.
AVIV HAIMPHARMOS CORP
BAILEY DON MLineage Cell Therapeutics, Inc.
Barak AviBIOCANCELL THERAPEUTICS INC.
BARRETT M JAMESPHARMOS CORP
BARRIS PETER JPHARMOS CORP
Ben-Am MoniqueBIOCANCELL THERAPEUTICS INC.
BEN DOR MONYPHARMOS CORP
Ben Gur JacobBIOCANCELL THERAPEUTICS INC.
BERGER FRANKLIN MLineage Cell Therapeutics, Inc.
Bergman ShellyBIOCANCELL THERAPEUTICS INC.
Boim AvivBIOCANCELL THERAPEUTICS INC.
BRADSHER NEAL CLineage Cell Therapeutics, Inc.
BROADWOOD CAPITAL INCLineage Cell Therapeutics, Inc.
BROADWOOD PARTNERS LPLineage Cell Therapeutics, Inc.
Burgin JonathanBIOCANCELL THERAPEUTICS INC.
BURNS ARNOLD ILineage Cell Therapeutics, Inc.
BUTLER ROBERT NLineage Cell Therapeutics, Inc.
Cartt Stephen LaHueLineage Cell Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lineage Cell Therapeutics, Inc.Listing on record	Jul 5, 2017	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 5, 2016	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 6, 2015	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Oct 10, 2014	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Oct 10, 2014	Buy	32,050	3.12 USD	$100K	conv 60ClusterFirst in 12mo	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 3, 2014	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Jan 27, 2006	AwardD (derivative)	20,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Feb 22, 2005	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Feb 24, 2004	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Lineage Cell Therapeutics, Inc.Listing on record	Jul 5, 2017	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 5, 2016	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 6, 2015	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Oct 10, 2014	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lineage Cell Therapeutics, Inc.Listing on record	Oct 10, 2014	Buy	32,050	3.12 USD	$100K	conv 60ClusterFirst in 12mo	SEC
Lineage Cell Therapeutics, Inc.Listing on record	Jul 3, 2014	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Jan 27, 2006	AwardD (derivative)	20,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Feb 22, 2005	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHARMOS CORPListing unverified	Feb 24, 2004	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC